Quantum Blue Portfolio Flyer - BI044ML 03E
Quantum Blue Portfolio Flyer - BI044ML 03E
Quantum Blue Portfolio Flyer - BI044ML 03E
BI044ML-03E
Quantum Blue®
Rapid Testing for Diagnosis and Monitoring of Inflammatory Diseases
Quantum Blue® Reader
The BÜHLMANN Quantum Blue® Reader is a compact and easy to use dedicated reader for in vitro
lateral flow assays. It uses a state of the art camera based image analysis system to measure
BÜHLMANN’s lateral flow assay portfolio. The Quantum Blue® Reader enables fast result reporting
close to the clinical environment, allowing immediate decision making leading to an optimized
clinical care. The assay menu of rapid tests for fecal calprotectin (fCAL) and therapeutic drug
monitoring (TDM) of anti-inflammatory biologics provides an indispensable toolset in diagnosis
and monitoring of inflammatory diseases such as Inflammatory Bowel Disease (IBD).
Fecal Calprotectin
Fecal calprotectin has proven itself as the key non-invasive biomarker to identify intestinal
inflammation throughout the gastrointestinal tract. Its excellent correlation with clinical endoscopy
and histology scores makes it the surrogate marker of choice to discriminate between organic
diseases like Inflammatory Bowel Disease (IBD) and non-organic disorders such as Irritable Bowel
Syndrome (IBS). Further, fecal calprotectin has shown to be a good predictor of relapse and
remission in IBD patients. The Quantum Blue® fCAL product line offers lateral flow-based
quantitative calprotectin test results for diagnosis and therapy follow-up of IBD patients within
12 to 15 minutes.
The Quantum Blue® fCAL extended and the Quantum 30 - 1000 µg/g
Blue® fCAL high range assays are designed with highly
specific monoclonal antibodies to capture the
calprotectin molecule. This allows for quantitative 100 - 1800 µg/g
measurement of fecal calprotectin. Both assays
correlate very well with the BÜHLMANN fCAL® ELISA
and BÜHLMANN fCAL® turbo as gold standard
laboratory methods.
Range 30–1000 µg/g 100–1800 µg/g 0.4–20 µg/mL qualitative assay 1.3–35 µg/mL qualitative assay
180 µg/mL with cut-off 1.3 μgeq/mL cut-off 0.2 μgeq/mL
dilution
Ordering Codes:
Quantum Blue® Reader BI-POCTR-ABS
Quantum Blue® fCAL extended LF-CALE25
Quantum Blue® and BÜHLMANN fCAL® are Quantum Blue® fCAL high range LF-CHR25
registered trademarks of BÜHLMANN in many Quantum Blue® Infliximab LF-TLIF10/ LF-TLIF25
countries.
BÜHLMANN Laboratories AG Phone +41 61 487 12 12 Quantum Blue® Anti-Infliximab LF-ADIF10/LF-ADIF25
Baselstrasse 55 Fax orders +41 61 487 12 99 Parts of the BÜHLMANN fCAL® and the Quantum Blue® Quantum Blue® Adalimumab LF-TLAD10/LF-TLAD25
fCAL kits are patent protected by: Quantum Blue® Anti-Adalimumab LF-ADAD10/LF-ADAD25
4124 Schönenbuch [email protected] EP2947459(B1); US10620216(B2); AU2015261919(B2);
Switzerland www.buhlmannlabs.ch JP6467436(B2) -marked products